Caristo Diagnostics logo — Medical Device for Vascular Disease Diagnosis

Caristo Diagnostics

Medical Device for Vascular Disease Diagnosis

Founded 2017 United Kingdom Oxford, United Kingdom 57 employees Series A Total: $15.05M

General Information

Company Name Caristo Diagnostics
Founded Year 2017
Location United Kingdom Oxford, United Kingdom +1
Employees 57
Funding Stage Series A

Get notified when Caristo Diagnostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Caristo Diagnostics

Caristo Diagnostics is a United Kingdom based startup that focuses on developing a Medical Device for Vascular Disease Diagnosis. Founded in 2017, the company aims to revolutionize cardiovascular diagnostic tools. By utilizing proprietary technology, Caristo Diagnostics enhances the accuracy of routine cardiac CT scans, extracting previously invisible information to predict cardiovascular risk and refine treatment decisions. The company recently secured a $150.00K Venture Round investment on 30 September 2024, with HeartX as the investing firm. Caristo Diagnostics demonstrates its commitment to innovation in the Biopharma, Health Care, and Medical Devices industries, striving to bring revolutionary advancements to patients worldwide. For more information, visit Caristo Diagnostics' website or follow them on Twitter.

Taxonomy: Medical Imaging, Cardiology, Heart Disease, Medicine, Clinical Trials, Cloud, Medical Device

Services & Products

Cardiac Diagnostics Technology and Services

Target Customers

Healthcare Professionals Clinics Patients

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $150.00K 1 01 Sep 2024
Series A £13.00M 5 Business Growth Fund 01 Apr 2023
Unknown Unknown 2 Business Growth Fund 01 Mar 2021
Support Program Unknown 1 Tech Nation 01 Sep 2020
Grant £1.90M - 01 Oct 2018

View All 6 Funding Rounds

Caristo Diagnostics Alternatives & Competitors

View All Alternatives
Caristo Diagnostics vs

Empowering seamless integration of top cardiology practices into a unified cardiovascular solution

Debt Financing
24 employees
Health Care
Caristo Diagnostics vs
Imageens
Imageens France

Building the future of clinical decision making in cardiovascular health with smart imaging biomarke...

Seed
5 employees
Medical Devices
Caristo Diagnostics vs

Developing advanced systems to enhance cerebral protection and minimize embolic strokes during cardi...

Series B
Health Care, Medical Devices

FAQ About Caristo Diagnostics

Medical Device for Vascular Disease Diagnosis
Caristo Diagnostics was founded in 2017.
Caristo Diagnostics is headquartered in Oxford, United Kingdom.
Caristo Diagnostics has approximately 57 employees.
Caristo Diagnostics has completed 6 funding rounds, raising a total of $15.05M. The latest funding stage is Series A.
Caristo Diagnostics offers: Cardiac Diagnostics Technology and Services.
Top alternatives and competitors to Caristo Diagnostics include Cardiovascular Logistics, Imageens, Embrella Cardiovascular, Foothill Cardiology Medical Group, Inc., BIBA Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Caristo Diagnostics and Cardiovascular Logistics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Caristo Diagnostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy